Afatinib Market Report

Afatinib Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Jan 16, 2020
  • PAGES：190
  • REPORT CODE：GMM437748
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Afatinib market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.3% during the forecast period.

    This report presents the market size and development trends by detailing the Afatinib market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Afatinib market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Afatinib industry and will help you to build a panoramic view of the industrial development.

    Afatinib Market, By Type:

    • 30mg Tables

    • 40mg Tables

    • 50mg Tables

    • 25mg Tables

    • 20mg Tables

    • Other

    Afatinib Market, By Application:

    • Hospital

    • Clinic

    • Drug Center

    • Other

    Some of the leading players are as follows:

    • Boehringer Ingelheim

    • Beacon Pharma

    • Hengrui Medicine

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Afatinib Market: Technology Type Analysis

    • 4.1 Afatinib Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Afatinib Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 30mg Tables

      • 4.3.2 40mg Tables

      • 4.3.3 50mg Tables

      • 4.3.4 25mg Tables

      • 4.3.5 20mg Tables

      • 4.3.6 Other

    5 Afatinib Market: Product Analysis

    • 5.1 Afatinib Product Market Share Analysis, 2018 & 2026

    • 5.2 Afatinib Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Afatinib Market: Application Analysis

    • 6.1 Afatinib Application Market Share Analysis, 2018 & 2026

    • 6.2 Afatinib Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Hospital

      • 6.3.2 Clinic

      • 6.3.3 Drug Center

      • 6.3.4 Other

    7 Afatinib Market: Regional Analysis

    • 7.1 Afatinib Regional Market Share Analysis, 2018 & 2026

    • 7.2 Afatinib Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Boehringer Ingelheim

      • 9.1.1 Boehringer Ingelheim Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Beacon Pharma

      • 9.2.1 Beacon Pharma Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Hengrui Medicine

      • 9.3.1 Hengrui Medicine Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

     

    The List of Tables and Figures (Totals 112 Figures and 123 Tables)

    • Figure 30mg Tables Afatinib market, 2015 - 2026 (USD Million)

    • Figure 40mg Tables Afatinib market, 2015 - 2026 (USD Million)

    • Figure 50mg Tables Afatinib market, 2015 - 2026 (USD Million)

    • Figure 25mg Tables Afatinib market, 2015 - 2026 (USD Million)

    • Figure 20mg Tables Afatinib market, 2015 - 2026 (USD Million)

    • Figure Other Afatinib market, 2015 - 2026 (USD Million)

    • Figure Hospital market, 2015 - 2026 (USD Million)

    • Figure Clinic market, 2015 - 2026 (USD Million)

    • Figure Drug Center market, 2015 - 2026 (USD Million)

    • Figure Other market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Afatinib market, by country, 2015 - 2026 (USD Million)

    • Table North America Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table North America Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table North America Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table Canada Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table Canada Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Europe Afatinib market, by country, 2015 - 2026 (USD Million)

    • Table Europe Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table Europe Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table Europe Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table Germany Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table Germany Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table France Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table France Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table Italy Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table Italy Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table Spain Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table Spain Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Afatinib market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table China Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table China Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table Japan Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table Japan Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table India Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table India Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Afatinib market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table MEA Afatinib market, by country, 2015 - 2026 (USD Million)

    • Table MEA Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table MEA Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table MEA Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Afatinib market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Afatinib market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Afatinib market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Beacon Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Hengrui Medicine Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US